UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Tyk2 Targeting in Immune-Mediated Inflammatory Diseases

International journal of molecular sciences, 2023-02, Vol.24 (4), p.3391

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator–controlled phase 3 AMAGINE-2 trial

Journal of the American Academy of Dermatology, 2020-02, Vol.82 (2), p.352-359

2020

Link zum Volltext

Verfügbarkeit prüfen

Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions

Journal of investigative dermatology, 2010-07, Vol.130 (7), p.1785-1796

2010

Link zum Volltext

Verfügbarkeit prüfen

IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications

International journal of molecular sciences, 2022-08, Vol.23 (16), p.9479

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Degree and Type of Sequelae After Involution of Untreated Hemangiomas of Infancy

JAMA dermatology (Chicago, Ill.), 2016-11, Vol.152 (11), p.1239

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials

Journal of the American Academy of Dermatology, 2016-12, Vol.75 (6), p.1156-1161

2016

Link zum Volltext

Verfügbarkeit prüfen

Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2

The Journal of dermatological treatment, 2020-08, Vol.31 (6), p.606-614

2020

Link zum Volltext

Verfügbarkeit prüfen

Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic

American journal of clinical dermatology, 2020-06, Vol.21 (3), p.307-311

2020

Link zum Volltext

Verfügbarkeit prüfen

Nomenclature and clinical phenotypes of atopic dermatitis

Therapeutic advances in chronic disease, 2021, Vol.12, p.20406223211002979-20406223211002979

2021

Link zum Volltext

Verfügbarkeit prüfen

Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis

The Journal of dermatological treatment, 2022-04, Vol.33 (3), p.1652-1660

2022

Link zum Volltext

Verfügbarkeit prüfen

PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries

Acta dermato-venereologica, 2023-08, Vol.103, p.adv6532-adv6532

2023

Link zum Volltext

Verfügbarkeit prüfen

Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2–3

Gynecologic oncology, 2006-11, Vol.103 (2), p.631-636

2006

Link zum Volltext

Verfügbarkeit prüfen

Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment

Dermatology and therapy, 2023-03, Vol.13 (3), p.673-688

2023

Link zum Volltext

Verfügbarkeit prüfen

The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases

Frontiers in immunology, 2023-08, Vol.14, p.1191782-1191782

2023

Link zum Volltext

Verfügbarkeit prüfen

Calibration of omnidirectional cameras in practice: A comparison of methods

Computer vision and image understanding, 2012, Vol.116 (1), p.120-137

2012

Link zum Volltext

Verfügbarkeit prüfen

Drug survival of conventional systemic and biologic therapies for moderate-to-severe psoriasis in clinical practice in Spain: prospective results from the SAHARA study

The Journal of dermatological treatment, 2020-05, Vol.31 (4), p.344-351

2020

Link zum Volltext

Verfügbarkeit prüfen

Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks

The Journal of dermatological treatment, 2023-12, Vol.34 (1), p.2263108-2263108

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis

Dermatology and therapy, 2021-06, Vol.11 (3), p.885-905

2021

Link zum Volltext

Verfügbarkeit prüfen

Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis

American journal of clinical dermatology, 2018-02, Vol.19 (1), p.23-32

2018

Link zum Volltext

Verfügbarkeit prüfen

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure

Dermatology and therapy, 2020-02, Vol.10 (1), p.133-150

2020

Link zum Volltext

Verfügbarkeit prüfen

JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors

Drugs (New York, N.Y.), 2020-03, Vol.80 (4), p.341-352

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan

Dermatology and therapy, 2024-01, Vol.14 (1), p.99-114

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension

Acta dermato-venereologica, 2018-01, Vol.98 (1), p.98-102

2018

Link zum Volltext

Verfügbarkeit prüfen

Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review

Dermatology and therapy, 2023-10, Vol.13 (10), p.2171-2185

2023

Link zum Volltext

Verfügbarkeit prüfen

Dystrophic Calcification in a Patient with Primary Localized Cutaneous Nodular Amyloidosis: An Uncommon Ultrasound Finding

Acta dermato-venereologica, 2018-01, Vol.98 (1), p.144-145

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.211

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.050)
Mit Volltextzugriff
(1.112)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Tyk2 Targeting in Immune-Mediated Inflammatory Diseases

Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator–controlled phase 3 AMAGINE-2 trial

Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions

IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications

Risk Factors for Degree and Type of Sequelae After Involution of Untreated Hemangiomas of Infancy

Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials

Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2

Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic

Nomenclature and clinical phenotypes of atopic dermatitis

Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis

PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries

Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2–3

Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment

The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases

Calibration of omnidirectional cameras in practice: A comparison of methods

Drug survival of conventional systemic and biologic therapies for moderate-to-severe psoriasis in clinical practice in Spain: prospective results from the SAHARA study

Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks

Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis

Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure

JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors

Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan

Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension

Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review

Dystrophic Calcification in a Patient with Primary Localized Cutaneous Nodular Amyloidosis: An Uncommon Ultrasound Finding

Suchergebnisse filtern